Core Laboratories Inc is a providers of proprietary and patented reservoir description and production enhancement services and products to the oil and gas industry, through client relationships. The company operates its business in two segments; Reservoir Description, and Production Enhancement. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services. The company generates majority of its revenue from Reservoir Description segment.
NOV Inc.
Halliburton Company
SLB Limited
Nabors Industries Ltd.
Patterson-UTI Energy Inc
Oceaneering International Inc.
Cactus, Inc.
Helmerich & Payne, Inc.
RPC, Inc.
OIL STATES INTERNATIONAL, INC.
The chart shows the growth of an initial investment of $10,000 in Core Laboratories Inc., comparing it to the performance of the S&P 500 index.
All prices have been adjusted for splits and dividends.
Core Laboratories Inc. (CLB) has returned 0.55% so far this year and 40.78% over the past 12 months. Looking at the last ten years, CLB has achieved an annualized return of -17.17%, underperforming the Benchmark (SPY), which averaged 12.23% per year.
The table below presents the monthly returns of Core Laboratories Inc. (CLB) with color gradation from worst to best to easily spot seasonal factors.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 20.32% | -7.76% | -6.51% | -0.85% | ||||||||
| 2025 | -3.36% | -13.99% | 2.53% | -23.38% | -5.12% | 4.82% | -5.45% | 7.07% | 7.48% | 29.59% | -5.74% | 6.44% |
| 2024 | -11.40% | -10.47% | 12.52% | -8.19% | 18.23% | 9.09% | 20.76% | -19.87% | -3.59% | 3.28% | 6.43% | -15.85% |
| 2023 | 28.45% | -5.20% | -7.70% | -3.10% | -1.17% | 5.30% | 11.02% | -7.07% | -2.04% | -9.81% | -18.31% | -0.11% |
| 2022 | 18.11% | 3.07% | 13.45% | -17.72% | 9.31% | -30.56% | -4.63% | -12.13% | -14.79% | 36.37% | 9.00% | -8.03% |
| 2021 | 22.10% | 5.93% | -20.54% | -4.02% | 45.29% | -8.22% | -17.22% | -16.51% | 0.04% | -7.27% | -12.70% | -5.75% |
| 2020 | -6.27% | -23.20% | -61.97% | 96.69% | 8.13% | 0.59% | 4.56% | -2.79% | -26.14% | -3.99% | 49.25% | 16.68% |
| 2019 | 15.38% | -3.90% | 5.19% | -8.54% | -24.61% | 9.24% | -6.45% | -20.18% | 20.65% | -6.18% | -1.93% | -14.56% |
| 2018 | 4.04% | -6.53% | 5.20% | 13.80% | 1.68% | 0.99% | -5.30% | 3.68% | 0.64% | -26.68% | -4.54% | -30.23% |
| 2017 | -3.86% | -3.07% | -0.24% | -4.11% | -7.71% | -1.21% | -1.17% | -12.23% | 11.75% | 2.06% | 0.48% | 7.89% |
| 2016 | 21.73% | -8.87% | 3.48% | -5.44% | -3.34% | 1.02% | -13.42% | 14.48% | 6.21% |
The charts below present risk-adjusted performance metrics for Core Laboratories Inc. (CLB) and compare them to a Benchmark (SPY). These indicators evaluate an investment's returns against its associated risks.
The Sharpe ratio helps investors understand how much return they're getting for the level of risk taken. A higher Sharpe ratio indicates better risk-adjusted performance, meaning more reward for each unit of risk.
These values reflect how efficiently the investment has delivered returns relative to its volatility over different time periods. All figures are annualized and based on daily total returns.
The chart below shows the rolling Sharpe ratio of CLB compared to the benchmark. This view highlights how the investment's risk-adjusted performance has changed over time.
The current Core Laboratories Inc. volatility is 3.19%, representing the standart deviation of percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
The Drawdowns chart displays portfolio losses from any high point along the way. It shows the maximum percentage drop from a peak to a trough over a specified period, indicating the risk of significant losses.
Although chart shows positive values, it represents the percentage drop from the peak, so a value of 10% means the portfolio has dropped 10% from its highest point.
The income statement provides a summary of a company's revenues, expenses, and profits over a specific period. It shows how much money the company earned (revenues) and how much it spent (expenses), leading to the net income or profit. This statement is crucial for understanding a company's financial performance and profitability.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Liabilities And Equity (USD) | 584.01M | 590.41M | 586.40M | 578.35M | 580.85M | 568.58M | 774.67M | 648.83M | 584.81M | 573.05M | 625.26M | 675.65M | 661.01M | 636.52M | 605.14M |
| Equity Attributable To Parent (USD) | 265.99M | 251.99M | 224.82M | 184.26M | 156.45M | 71.51M | 177.87M | 156.76M | 144.84M | 151.35M | -29.06M | 87.57M | 163.32M | 182.23M | 177.90M |
| Equity Attributable To Noncontrolling Interest (USD) | 6.22M | 5.75M | 4.99M | 4.70M | 4.55M | 4.06M | 4.28M | 4.14M | 3.89M | 3.94M | 5.37M | 6.42M | 6.07M | 5.68M | 3.75M |
| Equity (USD) | 272.21M | 257.74M | 229.81M | 188.95M | 161.00M | 75.57M | 182.14M | 160.90M | 148.73M | 155.30M | -23.70M | 93.99M | 169.39M | 187.91M | 181.66M |
| Other Non-current Liabilities (USD) | 92.79M | 107.08M | 102.49M | 111.27M | 139.07M | 142.26M | 173.94M | 93.38M | 103.06M | 95.73M | 92.96M | 93.79M | 88.82M | 74.02M | 60.60M |
| Long-term Debt (USD) | 113.00M | 128.00M | 166.00M | 175.00M | 190.00M | 261.00M | 307.00M | 292.00M | 228.00M | 218.00M | 435.24M | 356.00M | 267.03M | 234.07M | 225.42M |
| Noncurrent Liabilities (USD) | 205.79M | 235.08M | 268.49M | 286.27M | 329.07M | 403.26M | 480.94M | 385.38M | 331.06M | 313.73M | 528.20M | 449.79M | 355.85M | 308.09M | 286.02M |
| Other Current Liabilities (USD) | 42.22M | 40.14M | 35.80M | 33.86M | 40.22M | 40.20M | 49.29M | 38.84M | 34.43M | 50.89M | 50.81M | 50.17M | 45.99M | 50.42M | 45.79M |
| Wages (USD) | 26.53M | 22.90M | 18.79M | 23.43M | 20.83M | 26.53M | 26.69M | 22.55M | 28.89M | 19.41M | 36.48M | 34.62M | 38.97M | 34.92M | 34.03M |
| Accounts Payable (USD) | 37.28M | 34.55M | 33.51M | 45.85M | 29.73M | 23.03M | 35.61M | 41.16M | 41.70M | 33.72M | 33.47M | 47.08M | 50.82M | 55.17M | 57.64M |
| Current Liabilities (USD) | 106.02M | 97.59M | 88.10M | 103.14M | 90.78M | 89.75M | 111.59M | 102.55M | 105.02M | 104.02M | 120.76M | 131.87M | 135.78M | 140.51M | 137.46M |
| Liabilities (USD) | 311.80M | 332.67M | 356.59M | 389.40M | 419.85M | 493.01M | 592.53M | 487.93M | 436.08M | 417.76M | 648.96M | 581.66M | 491.62M | 448.60M | 423.48M |
| Other Non-current Assets (USD) | 262.78M | 260.33M | 256.71M | 254.14M | 272.71M | 287.44M | 412.48M | 281.88M | 244.89M | 246.77M | 233.46M | 214.18M | 207.37M | 205.47M | 200.81M |
| Intangible Assets (USD) | 7.12M | 6.40M | 6.93M | 7.48M | 8.14M | - | 17.45M | 13.05M | 9.40M | 9.94M | 10.04M | 10.64M | 10.95M | 8.72M | 8.22M |
| Fixed Assets (USD) | 99.45M | 97.06M | 99.63M | 105.03M | 110.95M | 115.29M | 123.51M | 122.92M | 123.10M | 129.88M | 143.21M | 149.01M | 138.82M | 125.42M | 115.30M |
| Noncurrent Assets (USD) | 369.35M | 363.80M | 363.26M | 366.65M | 391.80M | 402.73M | 553.44M | 417.85M | 377.39M | 386.59M | 386.71M | 373.83M | 357.14M | 339.61M | 324.33M |
| Other Current Assets (USD) | 150.44M | 157.03M | 143.28M | 135.59M | 129.55M | 112.90M | 155.12M | 169.96M | 161.52M | 142.03M | 185.59M | 244.20M | 243.92M | 232.68M | 227.60M |
| Prepaid Expenses (USD) | 9.73M | 10.18M | 8.15M | 15.67M | 14.06M | 14.80M | 15.95M | 15.35M | 12.59M | 10.71M | 12.05M | 14.25M | 13.13M | 14.96M | - |
| Inventory (USD) | 54.50M | 59.40M | 71.70M | 60.45M | 45.44M | 38.15M | 50.16M | 45.66M | 33.32M | 33.72M | 40.91M | 43.37M | 46.82M | 49.27M | 53.21M |
| Current Assets (USD) | 214.67M | 226.61M | 223.14M | 211.70M | 189.06M | 165.85M | 221.24M | 230.98M | 207.43M | 186.46M | 238.55M | 301.82M | 303.87M | 296.91M | 280.81M |
| Assets (USD) | 584.01M | 590.41M | 586.40M | 578.35M | 580.85M | 568.58M | 774.67M | 648.83M | 584.81M | 573.05M | 625.26M | 675.65M | 661.01M | 636.52M | 605.14M |
BP, a leading UK-based energy company, has announced plans to sell its onshore wind business in the United States as it refocuses on its solar partnership and other renewable energy sources. The move signals BP's shift from certain renewables despite previous efforts to diversify its energy portfolio.
Eni, Italy's leading oil and gas company, is in discussions to sell a minority stake in its renewable and retail business, Plenitude, to attract specialized investors and support its energy transition efforts.
SLB, an American oilfield services company, has announced a breakthrough in sustainable lithium production using its proprietary direct lithium extraction (DLE) technology. The company's solution is 500 times faster than conventional methods, with a significantly smaller environmental footprint.
Pembina Pipeline Corporation, a Canadian oil and gas storage and transportation company, has announced the acquisition of Veren Inc.'s Gold Creek and Karr area oil batteries for C$400 million. The deal strengthens Pembina's infrastructure and partnership with Veren, a prominent player in the Montney and Duvernay regions.
VANCOUVER, British Columbia, June 25, 2024 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. ("CLC" or the "Company") (CSE: CLC) is pleased to confirm that further to its news releases dated April 3, 2024, April 17, 2024, May 1, 2024, May 15, 2024, May 29, 2024, June 3, 2024, and June 18, 2024 (the "Releases"), the Company has filed on SEDAR its Q1 financial statements, accompanying management discussion and analysis and related CEO and CFO certifications for the period ended February 29, 2024 (the "Quarterly Filings"). The Quarterly Filings can be obtained on the Company's SEDAR profile at www.sedarplus.ca.
Christina Lake Cannabis has filed its audited financial statements for the year ended November 30, 2023.
VANCOUVER, British Columbia, June 03, 2024 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. ("CLC" or the "Company") (CSE: CLC) is providing an update with respect to the expected timeline for filing its audited financial statements for the fiscal year ended November 30, 2023, the related management's discussion and analysis and certificates of its CEO and CFO (collectively, the "Required Documents") and its previously announced management cease trade order ("MCTO") issued by the Company's principal regulator, the British Columbia Securities Commission (the "BCSC"), on April 3, 2024. As previously announced, pursuant to the MCTO, the CEO and CFO of the Company may not trade in securities of the Company until such time as the Company files the Required Documents and the BCSC revokes the MCTO. The MCTO does not affect the ability of other shareholders of the Company to trade in securities of the Company.
VANCOUVER, British Columbia, May 29, 2024 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. ("CLC" or the "Company") (CSE: CLC) is providing an update with respect to the expected timeline for filing its audited financial statements for the fiscal year ended November 30, 2023, the related management's discussion and analysis and certificates of its CEO and CFO (collectively, the "Required Documents") and its previously announced management cease trade order ("MCTO") issued by the Company's principal regulator, the British Columbia Securities Commission (the "BCSC"), on April 3, 2024. As previously announced, pursuant to the MCTO, the CEO and CFO of the Company may not trade in securities of the Company until such time as the Company files the Required Documents and the BCSC revokes the MCTO. The MCTO does not affect the ability of other shareholders of the Company to trade in securities of the Company.
Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
VANCOUVER, British Columbia, May 01, 2024 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. ("CLC" or the "Company") (CSE: CLC) is providing an update with respect to the expected timeline for filing its audited financial statements for the fiscal year ended November 30, 2023, the related management's discussion and analysis and certificates of its CEO and CFO (collectively, the "Required Documents") and its previously announced management cease trade order ("MCTO") issued by the Company's principal regulator, the British Columbia Securities Commission (the "BCSC"), on April 3, 2024. As previously announced, pursuant to the MCTO, the CEO and CFO of the Company may not trade in securities of the Company until such time as the Company files the Required Documents and the BCSC revokes the MCTO. The MCTO does not affect the ability of other shareholders of the Company to trade in securities of the Company.